Carfilzomib is approved for the treatment of multiple myleoma, a plasma cell cancer, often used in combination with other medicines with a similar therapeutic effect.
It is used to treat patients with relapsed or refractory multiple myeloma who have received previous treatments.
Frau Pharma, as a leading Carfilzomib Manufacturer & Supplier, produces high-purity Carfilzomib developed in our GMP-certified facilities. Our Carfilzomib Wholesale solutions are designed to meet the highest pharmaceutical standards.